Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Embolic Protection Device(s) EPDs are used to capture and remove plaque debris that are dislodged during interventional procedures. GlobalData uses proprietary data and analytics to provide a comprehensive report on the peripheral embolic protection devices market in Ireland. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the peripheral embolic protection devices market in Ireland was Abbott Laboratories followed by Boston Scientific, Cardiovascular Systems, Cordis and Medtronic.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Peripheral Embolic Protection devices (EPDs) used in the lower extremity, carotid and renal arteries have been accounted for. Carotid Embolic Protection devices and Lower Extremity Embolic Protection devices are tracked under this segment. Angioplasty: Angioplasty is a minimally invasive interventional procedure that is used to surgically unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures. A carotid embolic protection device is used during removal of plaque by an interventional procedure on the carotid artery. A lower extremity embolic protection device is used during a peripheral angioplasty.

The peripheral embolic protection devices market in Ireland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size peripheral embolic protection devices in Ireland, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.